Evidence map›Paper›PMID 42142157›Full record

ReviewGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2026

Living tissues and dead objects in the eye: The first description of ocular immune privilege by J.C. van Dooremaal in Albrecht Von Graefe's Archiv für Ophthalmologie in 1873.

Martine J Jager, Jacobus J Bosch, Hanneke W Mensink, Frédérique H van Dooremaal, Frits C Roest, Tero T Kivelä, Claus Cursiefen

Abstract readHistorical ArticleReview
In one paragraph

Review in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Martine J JagerDepartment of Ophthalmology, Leiden University Medical Center, PO Box 9600, Leiden, 2300 RC, The Netherlands. m.j.jager@lumc.nl.ORCID http://orcid.org/0000-0003-2261-3820
Jacobus J BoschDepartment of Ophthalmology, Leiden University Medical Center, PO Box 9600, Leiden, 2300 RC, The Netherlands.ORCID http://orcid.org/0000-0001-7653-885X
Hanneke W MensinkEye Hospital, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0002-1245-0549
Frédérique H van DooremaalUnitron Sonova, Vianen, The Netherlands.
Frits C RoestDepartment of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Tero T KiveläDepartment of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.ORCID http://orcid.org/0000-0003-1198-4394
Claus CursiefenDepartment of Ophthalmology, University of Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0002-1958-411X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundImmune privilege of the eye is considered to contribute significantly to the excellent survival of transplants in the anterior and posterior segment of the eye. While Sir Peter Medawar proved the existence of this phenomenon scientifically, a prior study by Dr. J.C. van Dooremaal already suggested the existence of ocular immune privilege and was published in this journal in 1873.

methodsThe original 1873 German paper by J.C. van Dooremaal in Albrecht von Graefe's Archiv für Ophthalmologie was translated into English and commented on by immunologist Dr. J. Wayne Streilein and other eye specialists. Family of Dr. van Dooremaal supplied information about the author himself.

resultsDr. van Dooremaal was a military doctor when he was confronted with a severe epidemic of trachoma while serving at the Government Institution of Benevolence in the Netherlands (now a UNESCO heritage site). While finding a solution to fight the epidemic, he became familiar with the eye clinic of professor F.C. Donders in Utrecht. He subsequently trained as an ophthalmologist, and worked on a thesis on implantation of foreign tissues in the anterior chamber of different animals. He observed that a piece of skin of a white mouse placed in the eye of a dog survived amazingly long and was integrated into the tissues of the anterior chamber instead of rejected. According to Dr. J. Wayne Streilein, this was the first experimental demonstration of ocular immune privilege.

conclusionThe 1873 paper by Dr. J.C. van Dooremaal can be regarded as the first description of ocular immune privilege, and as Dr. J. Wayne Streilein wrote in 2001: Dr. van Dooremaal is the FATHER of immune privilege - although he could not call it that since immunology had not yet been discovered.

Indexed as

Immune PrivilegeOphthalmologyTrachomaAnimalsGermanyHistory, 19th CenturyHumansHistory of medicineMedawarOcular immune privilegeRejectionToleranceTransplantation

Identifiers

PMID42142157
PMCPMC13578108

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.